The landscape of treating rare and chronic diseases is continually evolving, with targeted therapies leading the charge. Among the most promising areas of research is the inhibition of the complement system, a part of the immune system that, when overactivated, can contribute to numerous inflammatory conditions. At the heart of this new therapeutic wave lies Factor D, a crucial enzyme in the...